AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
Go back to AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring| Amgen Inc (NASDAQ: AMGN) | Delayed: 444.70 +0.86 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $443.84 | 52 Week High | $176.85 | |||
| Open | $443.26 | 52 Week Low | $133.64 | |||
| Day High | $447.03 | P/E | 66.97 | |||
| Day Low | $441.26 | EPS | $6.64 | |||
| Volume | 1,070,527 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,405,470 | |||||
